Publisher description for Critical pathways to success in CNS drug development / Neal R. Cutler ... [et al.].


Bibliographic record and links to related information available from the Library of Congress catalog


Information from electronic data provided by the publisher. May be incomplete or contain other coding.


Counter
Clinical Pathways to Success in CNS Drug Development provides a thorough overview of the critical early CNS drug development process for clinical scientists and reviews the latest models, technologies and regulations designed to improve and expedite the drug development process on each of the major CNS disorders. It includes a critical analysis of the lack of CNS specific drugs successfully brought to market and the steps required to remedy this problem. The book covers all of the initial stages of CNS drug development, from pre-clinical to early clinical trials, and includes all the latest technologies, methods, biomarkers, models and regulations designed to accelerate the early CNS drug development process, reduce overall costs, and improve drug safety and efficacy. It also discusses the many inherent difficulties in developing CNS-specific drugs, and describes the many technical and methodological advances used to circumvent these difficulties.


Library of Congress subject headings for this publication:
Neuropsychopharmacology.
Drug development.
Critical path analysis.
Central nervous system -- Effect of drugs on -- Research -- Methodology.
Central Nervous System Agents -- pharmacology.
Clinical Trials as Topic -- methods.
Drug Evaluation -- methods.
Drug Evaluation, Preclinical -- methods.